Citations

Clear

96 citation(s) found for "Sharrett, A".

Prospective associations of plasma phospholipids and mild cognitive impairment/dementia among African Americans in the ARIC Neurocognitive Study
Li, Danni , Misialek, Jeffrey R. , Boerwinkle, Eric , Sharrett, A. Richey, Wruck, Lisa , Alonso, Álvaro , Gottesman, Rebecca F. , Mosley, Thomas H. , Coresh, Josef , Knopman, David S. , Alonso, Alvaro , Wruck, Lisa M

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | November 1, 2016 | Volume: 6 | Issue: 1 | Pages: 1-10

10.1016/j.dadm.2016.09.003 | PMID 28054030 Get It

AbstractIntroductionThe objective of this study was to investigate whether 10 phospholipids/metabolites previously identified as prospectively predictive of mild cognitive impairment (MCI) or dementia in whites would also be predictive in a mostly African‐American cohort.MethodsWe repeatedly measured 188 phospholipids/metabolites in plasma samples of 221 participants of the Atherosclerosis Risk in Communities study, 97% African American, who were followed between 2004–2006 and 2011–2013.ResultsAfter a mean follow‐up of 7.3 years, 77 were classified as having MCI and 18 as having dementia. Our study failed to replicate previous findings in this mostly African American cohort, in that the 10 phospholipids/metabolites only achieved a C statistic/AUC of 0.609 in predicting development of MCI or dementia (compared to 0.96) and 0.607 in distinguishing normal from MCI or dementia at the follow‐up visit.ConclusionA panel of 10 phospholipids/metabolites previously associated with incident dementia was not predictive of MCI or dementia in an independent cohort.
O2‐09‐02: Midlife and Late Life Vascular Risk Factors and Microstructural Integrity Assessed Using Diffusion Tensor Imaging: The Aric‐NCS Study
Tingle, Jonathan V., Huang, Juebin , Sharrett, A. Richey , Griswold, Michael , Mosley, Tom, Power, Melinda C. , Reid, Robert I. , Coresh, Josef , Jack, Clifford R. , Knopman, David S. , Gottesman, Rebecca F.

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_5 | Pages: No page available

10.1016/j.jalz.2016.06.443 Get It

P2‐415: Association of Baseline Lipids with 20‐Year Cognitive Change: The ARIC Neurocognitive Study
Sharrett, A. Richey , Bandeen‐Roche, Karen , Pokharel, Yashashwi , Penman, Alan D. , Mosley, Tom, Power, Melinda C. , Rawlings, Andreea M. , Coresh, Josef , Ballantyne, Christie M. , Alonso, Álvaro , Knopman, David S. , Gottesman, Rebecca F.

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_16 | Pages: No page available

10.1016/j.jalz.2016.06.1627 Get It

O4‐10‐05: PLASMA PHOSPHOLIPIDS AND INCIDENT MILD COGNITIVE IMPAIRMENT/DEMENTIA IN THE ARIC NEUROCOGNITIVE STUDY (ARIC‐NCS)
Boerwinkle, Eric , Sharrett, Richey, Mosley, Tom, Li, Danni , Misialek, Jeffrey R. , Gottesman, Rebecca F. , Coresh, Josef , Wruck, Lisa , Knopman, David S. , Alonso, Álvaro

Mayo Clinic

Alzheimer's & Dementia | October 17, 2016 | Volume: 12 | Issue: 7S_Part_7 | Pages: No page available

10.1016/j.jalz.2016.06.664 Get It

Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC‐NCS)
Li, Danni , Misialek, Jeffrey R. , Boerwinkle, Eric , Sharrett, A. Richey, Wruck, Lisa , Gottesman, Rebecca F. , Mosley, Thomas H. , Coresh, Josef , Knopman, David S. , Alonso, Álvaro , Wruck, Lisa M

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | May 6, 2016 | Volume: 3 | Issue: 1 | Pages: 73-82

10.1016/j.dadm.2016.02.008 | PMID 27408938 Get It

AbstractIntroductionPhospholipids are altered in brains of patients with dementia and some studies suggest their plasma levels may be useful in the detection of mild cognitive impairment (MCI) and dementia.MethodsWe measured 188 plasma metabolites in participants who underwent a detailed neuropsychological assessment and classified as normal (n = 153), MCI (n = 145), or dementia (n = 143) by expert adjudication.ResultsAmong 10 phospholipids recently implicated as altered in dementia, higher concentration of PC aa C36:6 was significantly associated with decreased prevalence of dementia (odds ratio = 0.71, 95% confidence interval = 0.50–1.00 per 1−SD increase). Adding these phospholipids to a model including multiple predictors of dementia led to only minimal improvement in detection (C statistic changed from 0.702 to 0.71).DiscussionSome phospholipids and metabolites were altered in MCI and dementia but cross‐sectional association was relatively weak and did not improve detection of MCI and dementia beyond information provided by clinical variables.
Mild cognitive impairment and dementia prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study
Sharrett, Albert Richey, Wruck, Lisa , Windham, B. Gwen , Coker, Laura H., Schneider, Andrea L.C. , Sun, Hengrui, Alonso, Álvaro , Albert, Marilyn S. , Knopman, David S. , Gottesman, Rebecca F. , Sharrett, A. Richey, Coresh, Josef , Mosley, Thomas H. , Alonso, Alvaro , Schneider, Andrea L C , Wruck, Lisa M

Mayo Clinic

Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring | January 4, 2016 | Volume: 2 | Issue: 1 | Pages: 1-11

10.1016/j.dadm.2015.12.002 | PMID 26949733 Get It

AbstractIntroductionWe examined prevalence of mild cognitive impairment (MCI) and dementia in the Atherosclerosis Risk in Communities (ARIC) Neurocognitive study.MethodsBeginning in June, 2011, we invited all surviving ARIC participants to undergo cognitive, neurologic, and brain imaging assessments to diagnose MCI or dementia and assign an etiology for the cognitive disorder.ResultsOf 10,713 surviving ARIC participants (age range, 69–88 years), we ascertained cognitive diagnoses in 6471 in person, 1966 by telephone interviews (participant or informant), and the remainder by medical record review. The prevalence of dementia was 9.0% and MCI 21%. Alzheimer's disease (AD) was the primary or secondary etiology in 76% of dementia and 75% of MCI participants. Cerebrovascular disease was the primary or secondary etiology in 46% of dementia and 32% of MCI participants.DiscussionMCI and dementia were common among survivors from the original ARIC cohort. Nearly 30% of the ARIC cohort received diagnoses of either dementia or MCI, and for the majority of these individuals, the etiologic basis was attributed to AD.
Association of hospitalization with long-term cognitive and brain MRI changes in the ARIC cohort
Brown, Charles H. , Sharrett, A. Richey, Schneider, Andrea L.C. , Coresh, Josef , Alonso, Álvaro , Knopman, David S. , Mosley, Thomas H. , Gottesman, Rebecca F. , Schneider, Andrea L C

Mayo Clinic

Neurology | March 12, 2015 | Volume: 84 | Issue: 14 | Pages: 1443-1453

10.1212/wnl.0000000000001439 | PMID 25762715 Get It

Smoking and white matter hyperintensity progression
Sharrett, A. Richey , Jack, Clifford R. , Power, Melinda C. , Deal, Jennifer A. , Knopman, David S. , Mosley, Thomas H. , Gottesman, Rebecca F. , Jack, Clifford R

Mayo Clinic

Neurology | January 28, 2015 | Volume: 84 | Issue: 8 | Pages: 841-848

10.1212/wnl.0000000000001283 | PMID 25632094 Get It

Vascular Imaging Abnormalities and Cognition
Griswold, Michael , Lirette, Seth T. , Kantarci, Kejal , Sharrett, A. Richey , Graff‐Radford, Jonathan , Schneider, Andrea L.C. , Windham, B. Gwen , Coker, Laura H., Albert, Marilyn , Wruck, Lisa , Knopman, David S. , Gottesman, Rebecca F. , Jack, Clifford R. , Mosley, Thomas H. , Kantarci, Kejal , Lirette, Seth , Schneider, Andrea L C , Wruck, Lisa M

Mayo Clinic

Stroke | January 7, 2015 | Volume: 46 | Issue: 2 | Pages: 433-440

10.1161/strokeaha.114.007847 | PMID 25563642 Get It

Background and Purpose— The relationships between cerebrovascular lesions visible on imaging and cognition are complex. We explored the possibility that the cerebral cortical volume mediated these relationships. Methods— Total of 1906 nondemented participants (59% women; 25% African–American; mean age, 76.6 years) in the Atherosclerosis Risk in Communities (ARIC) study underwent cognitive assessments, risk factor assessments, and quantitative MRI for white matter hyperintensities (WMH) and infarcts. The Freesurfer imaging analysis pipeline was used to determine regional cerebral volumes. We examined the associations of cognitive domain outcomes with cerebral volumes (hippocampus and separate groups of posterior and frontal cortical regions of interest) and cerebrovascular imaging features (presence of large or small cortical/subcortical infarcts and WMH volume). We performed mediation pathway analyses to assess the hypothesis that hippocampal and cortical volumes mediated the associations between cerebrovascular imaging features and cognition. Results— In unmediated analyses, WMH and infarcts were both associated with worse psychomotor speed/executive function. In mediation analyses, WMH and infarct associations on psychomotor speed/executive function were significantly attenuated, but not abolished, by the inclusion of the posterior cortical regions of interest volume in the models, and the infarcts on psychomotor speed/executive function association were attenuated, but not abolished, by inclusion of the frontal cortical regions of interest volume. Conclusions— Both WMH and infarcts were associated with cortical volume, and both lesions were also associated with cognitive performance, implying shared pathophysiological mechanisms. Although cross-sectional, our findings suggest that WMH and infarcts could be proxies for clinically covert processes that directly damage cortical regions. Microinfarcts are 1 candidate for such a clinically covert process.
P3‐329: SMOKING AND WHITE MATTER HYPERINTENSITY GRADE PROGRESSION IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY
Sharrett, A. Richey , Power, Melinda C. , Deal, Jennifer A. , Jack, Clifford R. , Knopman, David S. , Mosley, Thomas H. , Gottesman, Rebecca F.

Mayo Clinic

Alzheimer's & Dementia | September 6, 2014 | Volume: 10 | Issue: 4S_Part_20 | Pages: No page available

10.1016/j.jalz.2014.05.1422 Get It